Your browser doesn't support javascript.
loading
Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC).
Ricceri, Fulvio; Fasanelli, Francesca; Giraudo, Maria Teresa; Sieri, Sabina; Tumino, Rosario; Mattiello, Amalia; Vagliano, Liliana; Masala, Giovanna; Quirós, J Ramón; Travier, Noemie; Sánchez, María-José; Larranaga, Nerea; Chirlaque, María-Dolores; Ardanaz, Eva; Tjonneland, Anne; Olsen, Anja; Overvad, Kim; Chang-Claude, Jenny; Kaaks, Rudolf; Boeing, Heiner; Clavel-Chapelon, Françoise; Kvaskoff, Marina; Dossus, Laure; Trichopoulou, Antonia; Benetou, Vassiliki; Adarakis, George; Bueno-de-Mesquita, H B As; Peeters, Petra H; Sund, Malin; Andersson, Anne; Borgquist, Signe; Butt, Salma; Weiderpass, Elisabete; Skeie, Guri; Khaw, Kay-Tee; Travis, Ruth C; Rinaldi, Sabina; Romieu, Isabelle; Gunter, Marc; Kadi, Mai; Riboli, Elio; Vineis, Paolo; Sacerdote, Carlotta.
Afiliação
  • Ricceri F; Unit of Cancer Epidemiology-CERMS, Department of Medical Sciences, University of Turin and Città Della Salute E Della Scienza Hospital, Turin, Italy.
  • Fasanelli F; Department of Mathematics "G. Peano", University of Turin, Turin, Italy.
  • Giraudo MT; Unit of Cancer Epidemiology-CERMS, Department of Medical Sciences, University of Turin and Città Della Salute E Della Scienza Hospital, Turin, Italy.
  • Sieri S; Department of Mathematics "G. Peano", University of Turin, Turin, Italy.
  • Tumino R; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy.
  • Mattiello A; Cancer Registry and Histopathology Unit, ", Civile M.P. Arezzo" Hospital, ASP, Ragusa, Italy.
  • Vagliano L; Dipartimento Di Medicina Clinica E Chirurgia, Università Federico II, Napoli, Italy.
  • Masala G; Department of Public and Pediatric Health Sciences, University of Turin, Turin, Italy.
  • Quirós JR; Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute ISPO, Florence, Italy.
  • Travier N; Public Health Directorate, Asturias, Spain.
  • Sánchez MJ; Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Institut Catalá d'Oncologia, Barcelona, Spain.
  • Larranaga N; Andalusian School of Public Health, Granada Bio-Health Research Institute (Granada.IBS), Granada, Spain.
  • Chirlaque MD; CIBER Epidemiología Y Salud Pública (CIBERESP), Spain.
  • Ardanaz E; Public Division of Gipuzkoa, Basque Regional Health Department and CIBERESP, San Sebastian, Spain.
  • Tjonneland A; CIBER Epidemiología Y Salud Pública (CIBERESP), Spain.
  • Olsen A; Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain.
  • Overvad K; CIBER Epidemiología Y Salud Pública (CIBERESP), Spain.
  • Chang-Claude J; Navarra Public Health Institute, Pamplona, Spain.
  • Kaaks R; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Boeing H; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Clavel-Chapelon F; Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Kvaskoff M; Unit of Genetic Epidemiology, Division of Cancer Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Dossus L; Unit of Genetic Epidemiology, Division of Cancer Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Trichopoulou A; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.
  • Benetou V; Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, F, -94805, Villejuif, France.
  • Adarakis G; University Paris Sud, UMRS 1018, F, -94805, Villejuif, France.
  • Bueno-de-Mesquita HB; Institute Gustave Roussy, F, -94805, Villejuif, France.
  • Peeters PH; Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, F, -94805, Villejuif, France.
  • Sund M; University Paris Sud, UMRS 1018, F, -94805, Villejuif, France.
  • Andersson A; Institute Gustave Roussy, F, -94805, Villejuif, France.
  • Borgquist S; Inserm, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health Team, F, -94805, Villejuif, France.
  • Butt S; University Paris Sud, UMRS 1018, F, -94805, Villejuif, France.
  • Weiderpass E; Institute Gustave Roussy, F, -94805, Villejuif, France.
  • Skeie G; WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
  • Khaw KT; Hellenic Health Foundation, Athens, Greece.
  • Travis RC; WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
  • Rinaldi S; Hellenic Health Foundation, Athens, Greece.
  • Romieu I; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Gunter M; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
  • Kadi M; Department of Epidemiology and Biostatistics, the School of Public Health, Imperial College London, London, United Kingdom.
  • Riboli E; Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Vineis P; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands.
  • Sacerdote C; Department of Surgical and Perioperative Sciences/Surgery, Umea University, Umea, Sweden.
Int J Cancer ; 137(4): 940-8, 2015 Aug 15.
Article em En | MEDLINE | ID: mdl-25650288
ABSTRACT
Women with a diagnosis of breast cancer are at increased risk of second primary cancers, and the identification of risk factors for the latter may have clinical implications. We have followed-up for 11 years 10,045 women with invasive breast cancer from a European cohort, and identified 492 second primary cancers, including 140 contralateral breast cancers. Expected and observed cases and Standardized Incidence Ratios (SIR) were estimated using Aalen-Johansen Markovian methods. Information on various risk factors was obtained from detailed questionnaires and anthropometric measurements. Cox proportional hazards regression models were used to estimate the role of risk factors. Women with breast cancer had a 30% excess risk for second malignancies (95% confidence interval-CI 18-42) after excluding contralateral breast cancers. Risk was particularly elevated for colorectal cancer (SIR, 1.71, 95% CI 1.43-2.00), lymphoma (SIR 1.80, 95% CI 1.31-2.40), melanoma (2.12; 1.63-2.70), endometrium (2.18; 1.75-2.70) and kidney cancers (2.40; 1.57-3.52). Risk of second malignancies was positively associated with age at first cancer, body mass index and smoking status, while it was inversely associated with education, post-menopausal status and a history of full-term pregnancy. We describe in a large cohort of women with breast cancer a 30% excess of second primaries. Among risk factors for breast cancer, a history of full-term pregnancy was inversely associated with the risk of second primary cancer.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Segunda Neoplasia Primária Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Int J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Segunda Neoplasia Primária Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: Int J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Itália